The latest obesity drug updates happening right now

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. 

Good morning. I’m still in denial that it’s the first day of October, but alas we have some biotech news to get to.

Atlas, Bain raise $400 million for new obesity startup

Atlas, Bain, and RTW Investments announced this morning that they have co-led a $400 million Series A financing for a new obesity startup called Kailera Therapeutics. It’s one of the largest Series A rounds in the biotech industry this year, and speaks to just how much attention obesity drugs have garnered from investors.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In